Based on the anti-neuroinflammatory role of TREM2 that has been proven in AD, in this study, we hypothesized whether TREM2 upregulation in microglia could be a potential strategy to impede M1 microglial-induced A1 astrocytes and neuronal toxicity. The gene discussed is TREM2; the disease is Alzheimer disease.